Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That's because they announced they had finished all prerequisites for MAA submission on the 8-29-2024. And then they followed it with Liau joining the board where the SP peaked and then they followed with fluff PRs up to the actual MAA submission and none could keep the SP afloat because the only other binary event to anticipate is MAA decision which simple math showed was 300+ days away.
He said he's long many times. Maybe quit worrying about what your next bullshit post will be and start actually paying attention the the few non-shills that have said they are invested yet have expressed issues with the company.
Such bullshit conspiracy theories. Maybe stop listening to flipper.
DCVax JAMA authors also authors of Jama's Optune trial article
Steven Brem
Steven Toms
Karen Fink
David Tran
So are these guys in on it? Whose side are they on? Can you please trash them like all other doctors who aren't involved with DCVax and don't think DCVax does shit?
And that's only JAMA publications. If DCVax worked, the two treatments could be used in conjunction as they are two totally different pathways but it's irrelevant because in their own study, DCVax is worse than placebo.
Coming soon: "For sale, built out CDMO in Sawston"
NWBO's record keeping failures
Guess that's how we relate your link to this company.
Flaskworks news would be when they start a comparability study.
10 years happens after 18 weeks. And a more likely time period for approval.
Nobody except delusional longs and shills on this board think this is "at the point of getting an approval decision". Even at the snowballs chance in hell of approval, there would be no reimbursement, just like there isn't for Optune. Companies at the point of getting an approval generally go up, not hit 52 week lows. They usually aren't toiling away on the OTC either. And those companies are at the point of getting approval from the FDA, not the MHRA, and there is no submission for solid cancers or combos with DCVax or anything else on your Fantasy Island.
Don't compare me to him. I've been correct the majority of the time. Being negative about a scammy company that hasn't produced anything since it went public in 2001 IS NOT the same as pumping a company that has lost shareholders 99.9% of stock price since 2001.
I'd bet. These fools bump their predictions each year. If you go back further, you can find "approval" from 2017 and on. I've said it will never be approved and I'll stick with that because I know what is required for approval and they are worlds away.
She was young and healthy when she got diagnosed. That alone is a huge prognostic factor in OS. Please read the link because I can’t spoon feed you everything. You are as bad as biosemoron.
I don’t remember anyone trying to intimidate LL. I only remember you trying to character assassinate every doctor who understands DCvax doesn’t work and the trial is garbage.
First off I’m not poor because I didn’t put all my money in this POS. Second, where is the complete dataset of the control arm? Hell , let’s see all the patient level data. They at least should have it for their own patients, even though despite the requirement for approval, they don’t have it for the control arm they are trying to use.
Why didn’t they release the whole data set in the JAMA article?
For the placebo arm of upcoming trials?
They didn’t release the entire set of data. Wonder why?
Can somebody swing by Sawston and see if the Advent “for sale” sign is up now?
1) Not the "historical SOC" you people keep comparing DCVax to. It's why control arms are important and why this trial has no chance.
2) again babbling bullshit. I showed you the actual percentage and compared to the latest total population GBM 5 year survival which is 6.9 % and includes non GTR patients which over the course of the 12 year long DCVax trial is around 40%. A much worse prognosis.
Do I need to explain math to you?
3) You are talking about the tiny mixed glioma P2 which had 6 patients and the ones without your adjuvant stimulant (only DCVax) did worse than SOC. Whoops.
4)
"Providing studies" includes a hyperling and throwing out BS and calling the facts should be quoted from the hyperlinks. Do you not know how to insert a link and a quote with all the useless walls of text you post every day?
Wooohooo, let's hope for ANY SIGN OF ORR this time! A great opportunity to finish building out Advent for LP to sell.
The National Brain Tumor Society has GBM 5 year survival at 6.9%
The Jama paper has 5 year survival of all who received DCVax at 9.1 percent. That's after weeding out the sick ones who didn't even qualify for the trial. You don't think selection criteria can increase 5 year survival by 2%? Considering GTR is a huge factor in OS, and the P3 weeded out incomplete resection, 2% is probable for the P3 patients. Most likely well over that.
So where is this "long tail" from DCVax again?
Run a well designed P3 trial.
Prove it works with results.
Submit a BLA.
This company failed the second two.
Do you think Theranos should’ve had their devices approved even though they were scams that didn’t work?
Pathetic is a company making millions on the false hope to cancer patients and their families. I’ll call it out til they fold or prove me wrong. I’ve got 15 minutes a day while I drink my coffee or finish my round of golf to call out this piece of crap. I’ve got plenty of free time because I don’t need to pump this company up 24/7 in hopes that the share price goes up so I can limit my dumb financial decision and sell.
I’m here because I had cancer and both parents died of cancer and I don’t like scamming pieces of shit making money off cancer patients.
I’ve admitted I lost a lot on Genvec. Same scam, different decade. Questionable data, changing endpoints, shady PRs. A Gaithersburg, MD company too.
Your minor investment is paying for Less to go on the big booze show and say stupid shit and LP to pump into Advent so she can sell it.
So nothing to do with NWBO? And it's DCs in a combo trial with Keytruda for a disease in which Keytruda is already approved.
You've jumped in front of the breadcrumb stage and have started with the wheat in the field that hasn't even been harvested yet.
Your owning of shares makes your opinion "compromised".
Shit has supposed to been hitting the fan since 2014.
The only shit is the company and it's product. I guess the fan is shareholders and patients.
To laugh at idiots like you. I admit I'm the easter bunny. Guess that's proof enough. 've said numerous times. I traded shares on this P&D, made money, and realized the company and shills are scum. I like discussing that. The reason you are so far down (yawn, I know, only on paper for eternity) is because you don't listen to those who obviously have more biotech trading experience than you, and have seen this dog and pony show before.
The comment section of the Jama article certainly is.
More random BS that has nothing to do with this otc POS or it’s expensive placebo. You are out flippering flipper with stale breadcrumbs.
Like the futility rec at the IA.
Your job is to post walls and walls of bullshit yet say nothing. Prove you own shares.
Everyone will be dead before Flaskworks “comes on board”. It was sold for pennies because that’s what it’s worth.